Suppr超能文献

MSH2、MSH6和MLH1基因多态性与肺癌患者易感性及生存率的关联

Association of MSH2, MSH6, and MLH1 polymorphisms with susceptibility and survival in lung cancer patients.

作者信息

Cheng Jing, Zuo Chao, Yang Dongli, Liu Yi, Wang Yu, Qiao Yongchao

机构信息

Department of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical University, Le Qun Road 15, Guilin, 541001, Guangxi, China.

Department of Pathology, The First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.

出版信息

Genes Genomics. 2025 Sep 10. doi: 10.1007/s13258-025-01681-4.

Abstract

BACKGROUND

Lung cancer (LC) is the leading cause of cancer-related deaths globally. Genetic variants in mismatch repair (MMR) genes, such as MutS homolog 2 (MSH2), MutS homolog 6 (MSH6) and MutL homolog 1 (MLH1), may influence individual susceptibility and clinical outcomes in LC.

OBJECTIVE

This study investigated the associations of genetic polymorphisms in MSH2, MSH6, and MLH1 with susceptibility and survival outcomes in lung cancer patients in the Guangxi Zhuang population.

METHODS

This study included a cohort of 192 LC patients and 262 healthy controls. The association of MSH2, MSH6, and MLH1 polymorphisms with susceptibility to small cell lung cancer (SCLC), lung adenocarcinoma (LUAD), and lung squamous carcinoma (LUSC) was evaluated using case-control methods, and protein expression differences were analysed by immunohistochemistry. The genotypes of genetic variations were detected using high-throughput SNP-scan technology. The Kaplan-Meier survival curve and log-rank test were used to assess the influence of individual genetic variants on prognostic outcomes in lung cancer patients.

RESULTS

Multivariate logistic regression identified significant associations of rs2303428 and rs1042821 with increased lung cancer risk, especially in SCLC and LUSC. The GA and GG genotypes of rs1042821 were linked to higher SCLC risk (OR = 4.415 and 2.685; P = 0.019), the TC genotype of rs2303428 was associated with elevated LUSC risk (OR = 3.993; P = 0.034). No associations were found for rs1800734 or in LUAD. Immunohistochemistry showed increased MSH2 and MSH6 expression in risk genotypes, with no genotype-related changes in MLH1. In LUAD, the CC genotype of rs2300789 was associated with poorer overall survival compared to TC (P = 0.047), with no significant differences in other comparisons.

CONCLUSION

rs2303428 and rs1042821 polymorphisms were associated with increased lung cancer susceptibility and altered protein expression. Additionally, the CC genotype of rs2300789 was linked to poorer overall survival in LUAD.

摘要

背景

肺癌(LC)是全球癌症相关死亡的主要原因。错配修复(MMR)基因中的遗传变异,如错配修复蛋白2(MSH2)、错配修复蛋白6(MSH6)和错配修复蛋白1(MLH1),可能会影响个体对肺癌的易感性和临床预后。

目的

本研究调查了广西壮族人群中MSH2、MSH6和MLH1基因多态性与肺癌患者易感性及生存结局的相关性。

方法

本研究纳入了192例肺癌患者和262例健康对照。采用病例对照方法评估MSH2、MSH6和MLH1基因多态性与小细胞肺癌(SCLC)、肺腺癌(LUAD)和肺鳞癌(LUSC)易感性的相关性,并通过免疫组织化学分析蛋白表达差异。使用高通量SNP扫描技术检测基因变异的基因型。采用Kaplan-Meier生存曲线和对数秩检验评估个体基因变异对肺癌患者预后结局的影响。

结果

多因素逻辑回归分析确定rs2303428和rs1042821与肺癌风险增加显著相关,尤其是在SCLC和LUSC中。rs1042821的GA和GG基因型与较高的SCLC风险相关(OR = 4.415和2.685;P = 0.019),rs2303428的TC基因型与LUSC风险升高相关(OR = 3.993;P = 0.034)。未发现rs1800734与LUAD存在相关性。免疫组织化学显示,风险基因型中MSH2和MSH6表达增加,MLH1未发现与基因型相关的变化。在LUAD中,rs2300789的CC基因型与TC基因型相比,总生存期较差(P = 0.047),其他比较无显著差异。

结论

rs2303428和rs1042821多态性与肺癌易感性增加及蛋白表达改变相关。此外,rs2300789的CC基因型与LUAD患者较差的总生存期相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验